Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mercedes Villarroya

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|April 28, 2004
ITH4012 (ethyl 5-amino-6,7,8,9-tetrahydro-2-methyl-4-phenylbenzol[1,8]naphthyridine-3-carboxylate), a novel acetylcholinesterase inhibitor with "calcium promotor" and neuroprotective propertiesCamilo Orozco, Cristobal de Los Rios, Esperanza Arias, et al.
European Journal of Pharmacology|October 19, 2006
Depolarization preconditioning produces cytoprotection against veratridine-induced chromaffin cell deathCamilo Orozco, Antonio M García-de-Diego, Esperanza Arias, et al.
Journal of Medicinal Chemistry|December 22, 2006
Novel multipotent tacrine-dihydropyridine hybrids with improved acetylcholinesterase inhibitory and neuroprotective activities as potential drugs for the treatment of Alzheimer's diseaseJosé Marco-Contelles, Rafael León, Cristóbal de Los Ríos, et al.
European Journal of Medicinal Chemistry|May 27, 2014
Dibenzo[1,4,5]thiadiazepine: a hardly-known heterocyclic system with neuroprotective properties of potential usefulness in the treatment of neurodegenerative diseasesGema C González-Muñoz, Mariana P Arce, Concepción Pérez, et al.
Bioorganic & Medicinal Chemistry|July 22, 2008
New tacrine-dihydropyridine hybrids that inhibit acetylcholinesterase, calcium entry, and exhibit neuroprotection propertiesRafael León, Cristóbal de los Ríos, José Marco-Contelles, et al.
European Journal of Medicinal Chemistry|March 1, 2017
Enzymatic and solid-phase synthesis of new donepezil-based L- and d-glutamic acid derivatives and their pharmacological evaluation in models related to Alzheimer's disease and cerebral ischemiaLeticia Monjas, Mariana P Arce, Rafael León, et al.
Journal of Medicinal Chemistry|June 16, 2010
Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer's disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing propertiesMaría Isabel Fernández-Bachiller, Concepción Pérez, Gema C González-Muñoz, et al.
Journal of Medicinal Chemistry|October 28, 2009
Neuroprotective and cholinergic properties of multifunctional glutamic acid derivatives for the treatment of Alzheimer's diseaseMariana P Arce, María Isabel Rodríguez-Franco, Gema C González-Muñoz, et al.
European Journal of Medicinal Chemistry|October 8, 2010
Old phenothiazine and dibenzothiadiazepine derivatives for tomorrow's neuroprotective therapies against neurodegenerative diseasesGema C González-Muñoz, Mariana P Arce, Beatriz López, et al.
Bioorganic & Medicinal Chemistry|April 15, 2004
Synthesis, biological evaluation and molecular modelling of diversely functionalized heterocyclic derivatives as inhibitors of acetylcholinesterase/butyrylcholinesterase and modulators of Ca2+ channels and nicotinic receptorsJosé L Marco, Cristóbal de los Ríos, Antonio G García, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
The Journal of Pharmacology and Experimental Therapeutics|April 28, 2004
ITH4012 (ethyl 5-amino-6,7,8,9-tetrahydro-2-methyl-4-phenylbenzol[1,8]naphthyridine-3-carboxylate), a novel acetylcholinesterase inhibitor with "calcium promotor" and neuroprotective propertiesCamilo Orozco, Cristobal de Los Rios, Esperanza Arias, et al.
European Journal of Pharmacology|October 19, 2006
Depolarization preconditioning produces cytoprotection against veratridine-induced chromaffin cell deathCamilo Orozco, Antonio M García-de-Diego, Esperanza Arias, et al.
Journal of Medicinal Chemistry|December 22, 2006
Novel multipotent tacrine-dihydropyridine hybrids with improved acetylcholinesterase inhibitory and neuroprotective activities as potential drugs for the treatment of Alzheimer's diseaseJosé Marco-Contelles, Rafael León, Cristóbal de Los Ríos, et al.
European Journal of Medicinal Chemistry|May 27, 2014
Dibenzo[1,4,5]thiadiazepine: a hardly-known heterocyclic system with neuroprotective properties of potential usefulness in the treatment of neurodegenerative diseasesGema C González-Muñoz, Mariana P Arce, Concepción Pérez, et al.
Bioorganic & Medicinal Chemistry|July 22, 2008
New tacrine-dihydropyridine hybrids that inhibit acetylcholinesterase, calcium entry, and exhibit neuroprotection propertiesRafael León, Cristóbal de los Ríos, José Marco-Contelles, et al.
European Journal of Medicinal Chemistry|March 1, 2017
Enzymatic and solid-phase synthesis of new donepezil-based L- and d-glutamic acid derivatives and their pharmacological evaluation in models related to Alzheimer's disease and cerebral ischemiaLeticia Monjas, Mariana P Arce, Rafael León, et al.
Journal of Medicinal Chemistry|June 16, 2010
Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer's disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing propertiesMaría Isabel Fernández-Bachiller, Concepción Pérez, Gema C González-Muñoz, et al.
Journal of Medicinal Chemistry|October 28, 2009
Neuroprotective and cholinergic properties of multifunctional glutamic acid derivatives for the treatment of Alzheimer's diseaseMariana P Arce, María Isabel Rodríguez-Franco, Gema C González-Muñoz, et al.
European Journal of Medicinal Chemistry|October 8, 2010
Old phenothiazine and dibenzothiadiazepine derivatives for tomorrow's neuroprotective therapies against neurodegenerative diseasesGema C González-Muñoz, Mariana P Arce, Beatriz López, et al.
Bioorganic & Medicinal Chemistry|April 15, 2004
Synthesis, biological evaluation and molecular modelling of diversely functionalized heterocyclic derivatives as inhibitors of acetylcholinesterase/butyrylcholinesterase and modulators of Ca2+ channels and nicotinic receptorsJosé L Marco, Cristóbal de los Ríos, Antonio G García, et al.
Pageof 5